This study is to see how ruxolitinib changes the breast cells when given to patients with premalignant breast conditions in order to know if it might…
This study is being done to learn more about the safety and effectiveness of an investigational oral medication called ORIN1001 for people with…
This study is being done to see if losing weight may help prevent breast cancer from coming back.
A study to determine the change from baseline to post-treatment Ki67 in some breast cancer tissue.
This study is being done to evaluate the safety and effectiveness of three different drug combinations for patients with HER2-positive metastatic…
The main purpose of this study is to look at the safety and effectiveness of the standard anti-HER2-targeted therapies.
RPC-3201: Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for…
M16-067: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects…
The goal of this study is to examine the effects of an acute bout of sedentary behaviors on cardiometabolic outcomes and energy metabolism in Latino…
This study will assess the effect of a 7-day course of oral cyclosporine (Neoral) on clinical outcome using the World Health Organization (WHO) COVID…